Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Segal

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of the American Geriatrics Society|September 1, 1997
The process of care in preventive in-home comprehensive geriatric assessmentC A Alessi, A E Stuck, H U Aronow, et al.
Nature|April 9, 2013
Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAXMyunggon Ko, Jungeun An, Hozefa S Bandukwala, et al.
The Lancet. Oncology|May 22, 2020
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trialYelena Y Janjigian, Steven B Maron, Walid K Chatila, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of the American Geriatrics Society|September 1, 1997
The process of care in preventive in-home comprehensive geriatric assessmentC A Alessi, A E Stuck, H U Aronow, et al.
Nature|April 9, 2013
Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAXMyunggon Ko, Jungeun An, Hozefa S Bandukwala, et al.
The Lancet. Oncology|May 22, 2020
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trialYelena Y Janjigian, Steven B Maron, Walid K Chatila, et al.
Pageof 3